acyclovir
Generic: acyclovir
Labeler: proficient rx lpDrug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
proficient rx lp
Dosage Form
TABLET
Routes
Active Ingredients
acyclovir 400 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
63187-253
Product ID
63187-253_9f75bb4a-0416-403f-92bc-a3d0e50457c6
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA203834
Listing Expiration
2026-12-31
Marketing Start
2013-11-29
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63187253
Hyphenated Format
63187-253
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA203834 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 400 mg/1
Packaging
- 15 TABLET in 1 BOTTLE (63187-253-15)
- 21 TABLET in 1 BOTTLE (63187-253-21)
- 25 TABLET in 1 BOTTLE (63187-253-25)
- 30 TABLET in 1 BOTTLE (63187-253-30)
- 60 TABLET in 1 BOTTLE (63187-253-60)
- 90 TABLET in 1 BOTTLE (63187-253-90)
Packages (6)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "9f75bb4a-0416-403f-92bc-a3d0e50457c6", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0363187253219"], "unii": ["X4HES1O11F"], "rxcui": ["197311"], "spl_set_id": ["c55bde35-a202-4c25-b545-e5d5e95c1175"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Proficient Rx LP"]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET in 1 BOTTLE (63187-253-15)", "package_ndc": "63187-253-15", "marketing_start_date": "20161003"}, {"sample": false, "description": "21 TABLET in 1 BOTTLE (63187-253-21)", "package_ndc": "63187-253-21", "marketing_start_date": "20150101"}, {"sample": false, "description": "25 TABLET in 1 BOTTLE (63187-253-25)", "package_ndc": "63187-253-25", "marketing_start_date": "20150901"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (63187-253-30)", "package_ndc": "63187-253-30", "marketing_start_date": "20141103"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (63187-253-60)", "package_ndc": "63187-253-60", "marketing_start_date": "20141103"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (63187-253-90)", "package_ndc": "63187-253-90", "marketing_start_date": "20141103"}], "brand_name": "Acyclovir", "product_id": "63187-253_9f75bb4a-0416-403f-92bc-a3d0e50457c6", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "63187-253", "generic_name": "Acyclovir", "labeler_name": "Proficient Rx LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "400 mg/1"}], "application_number": "ANDA203834", "marketing_category": "ANDA", "marketing_start_date": "20131129", "listing_expiration_date": "20261231"}